These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12814959)

  • 41. Glutathione transferase zeta-catalyzed bioactivation of dichloroacetic acid: reaction of glyoxylate with amino acid nucleophiles.
    Anderson WB; Board PG; Anders MW
    Chem Res Toxicol; 2004 May; 17(5):650-62. PubMed ID: 15144222
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Covalent binding and tissue distribution/retention assessment of drugs associated with idiosyncratic drug toxicity.
    Takakusa H; Masumoto H; Yukinaga H; Makino C; Nakayama S; Okazaki O; Sudo K
    Drug Metab Dispos; 2008 Sep; 36(9):1770-9. PubMed ID: 18508880
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bioactivation of the selective estrogen receptor modulator acolbifene to quinone methides.
    Liu J; Liu H; van Breemen RB; Thatcher GR; Bolton JL
    Chem Res Toxicol; 2005 Feb; 18(2):174-82. PubMed ID: 15720121
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motif.
    Kalgutkar AS; Driscoll J; Zhao SX; Walker GS; Shepard RM; Soglia JR; Atherton J; Yu L; Mutlib AE; Munchhof MJ; Reiter LA; Jones CS; Doty JL; Trevena KA; Shaffer CL; Ripp SL
    Chem Res Toxicol; 2007 Dec; 20(12):1954-65. PubMed ID: 17935300
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Photonucleophilic addition of the epsilon-amino group of lysine to a triflusal metabolite as a mechanistic key to photoallergy mediated by the parent drug.
    Montanaro S; Lhiaubet-Vallet V; Jiménez MC; Blanca M; Miranda MA
    ChemMedChem; 2009 Jul; 4(7):1196-202. PubMed ID: 19462393
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolic activation of tris(2,3-dibromopropyl)phosphate to reactive intermediates. II. Covalent binding, reactive metabolite formation, and differential metabolite-specific DNA damage in vivo.
    Pearson PG; Omichinski JG; Holme JA; McClanahan RH; Brunborg G; Søderlund EJ; Dybing E; Nelson SD
    Toxicol Appl Pharmacol; 1993 Feb; 118(2):196-204. PubMed ID: 8441998
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of 4-(5-chloro-2-hydroxyphenyl)-3-(2-hydroxyethyl)-6-(trifluoromethyl)-quinolin-2(1H)-one (BMS-223131), a novel opener of large conductance Ca2+-activated K+ (maxi-K) channels on normal and stress-aggravated colonic motility and visceral nociception.
    Sivarao DV; Newberry K; Langdon S; Lee AV; Hewawasam P; Plym MJ; Signor L; Myers R; Lodge NJ
    J Pharmacol Exp Ther; 2005 May; 313(2):840-7. PubMed ID: 15701710
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tissue distribution and elimination of N-methyl-N-2,4,6-tetranitroaniline (tetryl) in rats.
    Myers SR; Spinnato JA
    Arch Toxicol; 2007 Dec; 81(12):841-8. PubMed ID: 17680234
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence for the bioactivation of zomepirac and tolmetin by an oxidative pathway: identification of glutathione adducts in vitro in human liver microsomes and in vivo in rats.
    Chen Q; Doss GA; Tung EC; Liu W; Tang YS; Braun MP; Didolkar V; Strauss JR; Wang RW; Stearns RA; Evans DC; Baillie TA; Tang W
    Drug Metab Dispos; 2006 Jan; 34(1):145-51. PubMed ID: 16251255
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolic disposition of [14C]bazedoxifene in healthy postmenopausal women.
    Chandrasekaran A; McKeand WE; Sullivan P; DeMaio W; Stoltz R; Scatina J
    Drug Metab Dispos; 2009 Jun; 37(6):1219-25. PubMed ID: 19273530
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bioactivation of flutamide metabolites by human liver microsomes.
    Kang P; Dalvie D; Smith E; Zhou S; Deese A; Nieman JA
    Drug Metab Dispos; 2008 Jul; 36(7):1425-37. PubMed ID: 18411402
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro protein binding studies with BMS-204352: lack of protein binding displacement interaction in human serum.
    Krishna R; Yao M; Kaczor D; Vachharajani N; Srinivas NR
    Biopharm Drug Dispos; 2001 Jan; 22(1):41-4. PubMed ID: 11745906
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
    Antal-Zimanyi I; Bruce MA; Leboulluec KL; Iben LG; Mattson GK; McGovern RT; Hogan JB; Leahy CL; Flowers SC; Stanley JA; Ortiz AA; Poindexter GS
    Eur J Pharmacol; 2008 Aug; 590(1-3):224-32. PubMed ID: 18573246
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Covalent binding of the phenacetin metabolite p-nitrosophenetole to protein.
    Hinson JA; Mays JB
    J Pharmacol Exp Ther; 1986 Jul; 238(1):106-12. PubMed ID: 3723393
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bioactivation and covalent binding of halothane in vitro: studies with [3H]- and [14C]halothane.
    Gandolfi AJ; White RD; Sipes IG; Pohl LR
    J Pharmacol Exp Ther; 1980 Sep; 214(3):721-5. PubMed ID: 7400975
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of the major protein adduct formed in rat liver after thioacetamide administration.
    Dyroff MC; Neal RA
    Cancer Res; 1981 Sep; 41(9 Pt 1):3430-5. PubMed ID: 6790164
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo covalent binding of [14C]trinitrotoluene to proteins in the rat.
    Liu YY; Lu AY; Stearns RA; Chiu SH
    Chem Biol Interact; 1992 Mar; 82(1):1-19. PubMed ID: 1547511
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo metabolism of [14C]ruboxistaurin in dogs, mice, and rats following oral administration and the structure determination of its metabolites by liquid chromatography/mass spectrometry and NMR spectroscopy.
    Barbuch RJ; Campanale K; Hadden CE; Zmijewski M; Yi P; O'Bannon DD; Burkey JL; Kulanthaivel P
    Drug Metab Dispos; 2006 Feb; 34(2):213-24. PubMed ID: 16258078
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Species-specific, P450- and sulfotransferase-mediated novel ring contraction of a naphthyridine-N-oxide compound in cynomolgus monkey.
    Daniels JS; Espina R; Cao K; Yuan H; Lin J; Diamond S; Johnson B; Rodgers J; Prakash S; Unger S; Christ D; Miwa G; Gan LS; Mutlib A
    Chem Res Toxicol; 2007 Nov; 20(11):1709-17. PubMed ID: 17939741
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of early phase adjuvant arthritis on hepatic P450 enzymes and pharmacokinetics of verapamil: an alternative approach to the use of an animal model of inflammation for pharmacokinetic studies.
    Ling S; Jamali F
    Drug Metab Dispos; 2005 Apr; 33(4):579-86. PubMed ID: 15659540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.